Amgen (AMGN) Other Non-Current Liabilities (2009 - 2026)
Amgen's Other Non-Current Liabilities came in at $2.84 billion for Q2 2026, up 13.3% from $2.51 billion a year earlier and up 2.9% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Other Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Amgen's Other Non-Current Liabilities was $2.69 billion, up 14.5% from FY2024.
- Other Non-Current Liabilities carries a five-year compound annual growth rate of 141.1% (FY2020 to FY2025).
- Going back by year, Other Non-Current Liabilities was $2.35 billion in FY2024 (-49.8%), $4.68 billion in FY2023, $270 million in FY2022 (-21.1%) and $342 million in FY2021 (+936.4%).
- The Q2 2026 figure represents the highest quarterly Other Non-Current Liabilities since Q4 2023.
- Year-over-year, Other Non-Current Liabilities has increased for four consecutive quarters, with growth averaging 1.4% over the last five quarters.
- The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q4 2021 (growth of 936.4%), and the weakest in Q3 2023 (a decline of 98.3%).
- Business Quant data shows AMGN's Other Non-Current Liabilities at $2.76 billion (Q1 2026), $2.69 billion (Q4 2025) and $2.62 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 128.38 Bn | 100.39 Bn | 2.84 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.84 Bn |
| Mar 31, 2026 | 2.76 Bn |
| Dec 31, 2025 | 2.69 Bn |
| Sep 30, 2025 | 2.62 Bn |
| Jun 30, 2025 | 2.51 Bn |
| Mar 31, 2025 | 2.42 Bn |
| Dec 31, 2024 | 2.35 Bn |
| Sep 30, 2024 | 2.28 Bn |
| Jun 30, 2024 | 107.00 Mn |
| Mar 31, 2024 | 96.00 Mn |
| Dec 31, 2023 | 4.68 Bn |
| Sep 30, 2023 | 98.00 Mn |
| Jun 30, 2023 | 248.00 Mn |
| Mar 31, 2023 | 273.00 Mn |
| Dec 31, 2022 | 270.00 Mn |
| Sep 30, 2022 | 5.68 Bn |
| Jun 30, 2022 | 5.60 Bn |
| Mar 31, 2022 | 6.65 Bn |
| Dec 31, 2021 | 342.00 Mn |
| Sep 30, 2021 | 6.48 Bn |
API Access
Amgen Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();